Global healthcare data, analytics and clinical research company serving life sciences, with a 22,000 plus person delivery base in India
iqvia.comLegal name
IQVIA Holdings Inc.
CFO
Mike Fedock, Executive Vice President and Chief Financial Officer
Founded
1982 as Quintiles; IQVIA formed in 2016 from the Quintiles and IMS Health merger and renamed in 2017
Headquarters
Durham, North Carolina, USA; India registered office at One Lodha Place, Lower Parel, MumbaiEmployees
About 93,000 globally, 22,000+ in India
Industry
Healthcare data and analytics, clinical research (CRO), health information technology
Revenue (FY25)
$16.31 billion, up 5.87% year on year
Market Cap
About $33.13 billion (July 2026)
Listed on
NYSE: IQV, an S&P 500 component
IQVIA Holdings Inc. is an American healthcare data, analytics and clinical research company listed on the NYSE under the ticker IQV. It was formed in 2016 when Quintiles, the contract research organization incorporated in North Carolina in 1982, merged with the healthcare data provider IMS Health. The combined business took the IQVIA name in 2017, where the I stands for IMS Health, the Q for Quintiles and VIA for by way of. The company is headquartered in Durham, North Carolina.
The business sells analytics, technology platforms and clinical research services to pharmaceutical, biotech, medtech and consumer health customers, and reports through two segments: Commercial Solutions and R&D Solutions. Work spans Phase I to Phase IV clinical trials, laboratory services, real world evidence, pharmacovigilance and regulatory compliance, plus commercial data products sold through its Connected Intelligence platform. FY2025 revenue was $16.31 billion, and first quarter 2026 revenue was $4,151 million, up 8.4% year on year, with full year 2026 guidance reaffirmed at $17.15 billion to $17.35 billion. Roughly 93,000 people work for IQVIA across more than 100 countries.
India is one of IQVIA's largest delivery bases, with more than 22,000 employees across cities including Bengaluru, Mumbai, Thane, Gurugram, Delhi, Noida, Pune, Hyderabad, Chennai, Kolkata and Ahmedabad. The main India operating entity for clinical work is IQVIA RDS (India) Private Limited, registered in Bangalore, which reported FY2025 revenue of about Rs 3,342 crore. India teams cover clinical data management, database design, safety and pharmacovigilance, statistical programming, technology engineering and consulting.
Chairman and Chief Executive Officer
Executive Vice President, Chief Financial Officer
Executive Vice President, Chief Human Resources Officer
President, Commercial Solutions
Interview experience
Favourable, 7 out of 10
Interview difficulty
Medium, 6 out of 10
Interview process length
About a week to two weeks for most candidates
Practise real IQVIA questions, get instant feedback and walk in ready for every round.
Q: Walk me through the early stages: what happens after the HR phone screen and what does the assessment cover?
A: Candidates report a short HR phone screening first, then an AMCAT style online test with an aptitude and logical reasoning section plus an English grammar section. Treat it as a timed screening filter rather than a domain test.
Q: SAS questions and SDTM variables: what should you be ready to explain?
A: Expect direct technical questions on SAS procedures and data steps alongside SDTM domain structure and variable naming. Be ready to explain how raw clinical data maps into standardised domains.
Q: In DBMS, which data structure is used?
A: Interviewers want the B tree and B+ tree answer for indexing, with hashing mentioned for equality lookups. Add why B+ trees suit range queries and disk based storage.
Q: Which is your favourite subject and why?
A: This checks depth, not preference. Pick a subject that connects to the analyst role, give one concrete thing you built or solved in it, and say what you'd still like to learn.
Practise real IQVIA questions, get instant feedback and walk in ready for every round.
Average across submissions
₹15,07,157/year
24 salaries Salaries submitted
Average across submissions
₹21,83,090/year
7 salaries Salaries submitted
Average across submissions
₹10,22,210/year
12 salaries Salaries submitted
Average across submissions
₹9,51,985/year
29 salaries Salaries submitted
Average across submissions
₹15,93,897/year
13 salaries Salaries submitted
Average across submissions
₹9,72,036/year
7 salaries Salaries submitted
Benchmark your pay against live market data before you negotiate.
Bengaluru • Not specified
Bengaluru • Not specified
Bengaluru • Not specified
Bengaluru • Not specified
Kochi • Full-time
Kochi • Full-time
Tailor your resume to each IQVIA posting in minutes and get past the screen.
May 13, 2026
IQVIA and Kexing Biopharm expand biosimilar collaboration
IQVIA expanded its strategic collaboration with Kexing Biopharm to support a global, multi product biosimilar development and commercialization program using AI enabled clinical capabilities. The work covers clinical development, regulatory strategy, analytics and commercialization for international markets.
#Partnership #Biosimilars #AI
View postMay 5, 2026
IQVIA reports first quarter 2026 results
Revenue reached $4,151 million, up 8.4% reported and 6.0% at constant currency, with Commercial Solutions at $1,754 million and R&D Solutions at $2,397 million. The company reaffirmed full year revenue guidance of $17.15 billion to $17.35 billion and raised adjusted diluted EPS guidance to $12.65 to $12.95.
#Earnings #Financials
View postFebruary 25, 2026
IQVIA to acquire drug discovery assets from Charles River Laboratories
IQVIA signed an agreement to buy five in vitro drug discovery sites from Charles River Laboratories, including lab based New Approach Methodologies and a small molecule AI platform. The deal was expected to close in the second quarter of 2026.
#Acquisition #DrugDiscovery
View postJanuary 29, 2026
Boehringer Ingelheim picks IQVIA DaaS+ for global commercial data transformation
Boehringer Ingelheim selected IQVIA's Data as a Service platform to harmonize commercial data reporting across 59 countries. The long term collaboration supports brand and franchise reporting plus upcoming product launches.
#Partnership #Data
View postSeptember 2, 2025
IQVIA announces CFO transition for early 2026
Michael Fedock, then SVP of Financial Planning and Analysis, was named Executive Vice President and Chief Financial Officer effective February 28, 2026. He succeeded Ron Bruehlman, who retired as CFO and stayed on as senior advisor to CEO Ari Bousbib.
#Leadership #CFO
View postIQVIA sells healthcare data, analytics, technology platforms and clinical research services to pharmaceutical, biotech, medtech and consumer health customers. It reports through two segments, Commercial Solutions and R&D Solutions, covering Phase I to Phase IV trials, lab services, real world evidence, pharmacovigilance and commercial data products.
